JANUX THERAPEUTICS INC's ticker is JANX and the CUSIP is 47103J105. A total of 121 filers reported holding JANUX THERAPEUTICS INC in Q1 2024. The put-call ratio across all filers is 1.75 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $241,035 | -15.1% | 5,754 | -23.7% | 0.01% | -14.3% |
| Q1 2024 | $284,032 | +86.4% | 7,544 | -46.9% | 0.01% | +75.0% |
| Q4 2023 | $152,409 | +42.6% | 14,204 | +34.0% | 0.00% | +33.3% |
| Q3 2023 | $106,868 | -10.1% | 10,602 | +5.9% | 0.00% | 0.0% |
| Q2 2023 | $118,819 | – | 10,010 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 9,165,652 | $383,949,162 | 5.08% |
| Logos Global Management LP | 750,000 | $31,417,500 | 2.55% |
| Cormorant Asset Management, LP | 1,050,000 | $43,984,500 | 2.54% |
| Paradigm Biocapital Advisors LP | 1,564,452 | $65,534,894 | 2.51% |
| Orbimed Advisors | 2,979,828 | $124,824,995 | 2.46% |
| Vestal Point Capital, LP | 725,000 | $30,370,250 | 2.26% |
| EcoR1 Capital, LLC | 1,469,818 | $61,570,676 | 1.88% |
| Avidity Partners Management LP | 840,219 | $35,196,774 | 1.50% |
| Ratan Capital Management LP | 105,757 | $4,430,160 | 1.34% |
| STEMPOINT CAPITAL LP | 92,949 | $3,893,634 | 1.14% |